Superworth

Ernexa Therapeutics price to book ratio ERNA

Market value divided by the book value of the company's net assets, since 2013.

Today, Oct 23, 2026
1.1×
10-year median
2.3×
Against its 10-year history
11th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.6× to 87.1×
Peer median
1.0×

Ernexa Therapeutics' price to book ratio is 1.1× as of Oct 23, 2026.

That is below its ten-year median of 2.3×, lower than on 89% of days in the last ten years.

Over that time it ranged from 0.6× in Jul 2026 to 87.1× in Apr 2021.

The median for 10 healthcare stocks of a similar size is 1.0×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.1×0.6×3.7×
20252.7×2.0×8.1×
20244.9×2.1×5.8×
20232.7×1.1×3.4×
20221.1×0.6×15.4×
202116.6×6.6×87.1×
202013.4×0.6×13.4×
20191.0×0.8×1.7×
20180.8×0.8×3.1×
20171.8×1.6×11.8×
201610.7×2.3×12.5×
20153.1×2.1×6.6×
20143.3×2.2×6.9×
20135.7×5.7×7.7×

Against its peers

Companies in Healthcare nearest Ernexa Therapeutics' size, closest first, today.

CompanyPrice to book ratio
ERNAErnexa Therapeutics1.1×
OXBROXBRIDGE RE HOLDINGS1.2×
EDUCEducational Development0.2×
GTIMGood Times Restaurants0.4×
MDRRMedalist Diversified0.6×
BCGBinah Capital0.9×
VIPVulcan Infrastructure & Powern/m
MXCMexco Energy1.0×
CKXCKX Lands1.0×
MSGMMotorsport Games5.8×
ATCHAtlasClear1.1×
Peer median1.0×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Ernexa Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.